16 Results for "

insulinotropic agent

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "insulinotropic agent" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B0682A
CAS No.: 207844-01-7
Synonyms: KAD-1229; S-21403
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease

Mitiglinide calcium hydrate (KAD-1229), an insulinotropic agent, is an ATP-sensitive K + (KATP) channel antagonist. Mitiglinide calcium hydrate is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium hydrate can be used for the research of type 2 diabetes .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-17398
CAS No.: 145525-41-3
Synonyms: KAD-1229 anhydrous; S21403 anhydrous
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease

Mitiglinide Calcium (KAD-1229 anhydrous), an insulinotropic agent, is an ATP-sensitive K + (KATP) channel antagonist. Mitiglinide Calcium is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-B0422
CAS No.: 105816-04-4
Synonyms: A4166; Senaglinide
Research Areas:  

Metabolic Disease

Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K + channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus .
loading...
    loading...
Cat. No.: HY-108767
CAS No.: 116094-23-6
Purity:  ≥95.0%
Synonyms: B28Asp; B28-Asp-insulin; INA-X 14; Insulin X 14
Research Areas:  

Metabolic Disease

Insulin aspart (B28Asp) is a rapid-acting h-Insulin (HY-P0035) analog. Insulin aspart induces a faster hypoglycemic effect. Insulin aspart can be used in diabetes-related research .
loading...
    loading...
Cat. No.: HY-B0682
CAS No.: 145375-43-5
Synonyms: KAD-1229 free acid anhydrous; S21403 free acid anhydrous
Target:  

Potassium Channel

Research Areas:  

Metabolic Disease

Mitiglinide (KAD-1229), an insulinotropic agent, is an ATP-sensitive K + (KATP) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-B0422S
CAS No.: 1227666-13-8
Synonyms: A4166 d5; Senaglinide d5
Nateglinide-d5 is a deuterium labeled Nateglinide. Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K+ channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus[1][2].
loading...
    loading...
Cat. No.: HY-126198
CAS No.: 75358-37-1
Synonyms: McN-3935
Target:  

Antibiotic

Research Areas:  

Metabolic Disease

Linogliride (MCN-3935) is an antidiabetic agent. Linogliride (100 μM) does not affect insulin secretion in the absence of glucose, but has a significant insulinotropic effect in the presence of 5.5 mM glucose .
loading...
    loading...
Cat. No.: HY-126198A
CAS No.: 78782-47-5
Synonyms: McN-3935 fumarate
Target:  

Antibiotic

Research Areas:  

Metabolic Disease

Linogliride (MCN-3935) fumarate is an antidiabetic agent. Linogliride fumarate (100 μM) does not affect insulin secretion in the absence of glucose, but has a significant insulinotropic effect in the presence of 5.5 mM glucose .
loading...
    loading...
Cat. No.: HY-B0422R
CAS No.: 105816-04-4
Synonyms: A4166 (Standard); Senaglinide (Standard)
Nateglinide (Standard) is the analytical standard of Nateglinide. This product is intended for research and analytical applications. Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K + channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus .
loading...
    loading...
Cat. No.: HY-B0682S2
Mitiglinide-d5 (calcium) is deuterium labeled Mitiglinide. Mitiglinide (KAD-1229), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-B0682S1
(2R)-Mitiglinide-d5 (calcium) is deuterium labeled Mitiglinide. Mitiglinide (KAD-1229), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-B0682AR
CAS No.: 207844-01-7
Synonyms: KAD-1229 (Standard); S-21403 (Standard)
Research Areas:  

Metabolic Disease

Mitiglinide (calcium hydrate) (Standard) is the analytical standard of Mitiglinide (calcium hydrate). This product is intended for research and analytical applications. Mitiglinide calcium hydrate (KAD-1229), an insulinotropic agent, is an ATP-sensitive K + (KATP) channel antagonist. Mitiglinide calcium hydrate is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium hydrate can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-17398R
CAS No.: 145525-41-3
Synonyms: KAD-1229 anhydrous (Standard); S21403 anhydrous (Standard)
Research Areas:  

Metabolic Disease

Mitiglinide (calcium) (Standard) is the analytical standard of Mitiglinide (calcium). This product is intended for research and analytical applications. Mitiglinide Calcium (KAD-1229 anhydrous), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide Calcium is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-W777434
Mitiglinide (calcium hydrate)-d8 is the deuterium labeled Mitiglinide (calcium hydrate) (HY-B0682A). Mitiglinide calcium hydrate (KAD-1229), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide calcium hydrate is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium hydrate can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-B0682S
Mitiglinide-d8 calcium hydrate (KAD-1229-d8) is the deuterium labeled Mitiglinide calcium hydrate. Mitiglinide calcium hydrate (KAD-1229), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide calcium hydrate is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium hydrate can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-19174
CAS No.: 161748-40-9
BTS-67582 is an orally active nonsulfonylurea insulinotropic agent and potassium channel blocker. BTS-67582 affects the K + ATP channel in the islet cell but at a different binding site than the sulfonylureas. BTS-67582 is an antidiabetic agent .
loading...
    loading...
  • 1